166 related articles for article (PubMed ID: 37156819)
21. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
22. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
23. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
Yu Y; Cheng J; Mei CZ; Dai YZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
[TBL] [Abstract][Full Text] [Related]
24. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
Ma X; Ding Y; Zeng L
BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382
[TBL] [Abstract][Full Text] [Related]
25. Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration.
Nong JS; Zhou X; Liu JQ; Luo JZ; Huang JM; Xie HX; Yang KJ; Wang J; Ye XP; Peng T
Cancer Med; 2023 May; 12(9):10990-11009. PubMed ID: 36952458
[TBL] [Abstract][Full Text] [Related]
26. Exploring novel independent prognostic biomarkers for hepatocellular carcinoma based on TCGA and GEO databases.
Hou M
Medicine (Baltimore); 2022 Oct; 101(43):e31376. PubMed ID: 36316888
[TBL] [Abstract][Full Text] [Related]
27. M2-like tumor-associated macrophage-related biomarkers to construct a novel prognostic signature, reveal the immune landscape, and screen drugs in hepatocellular carcinoma.
Qu X; Zhao X; Lin K; Wang N; Li X; Li S; Zhang L; Shi Y
Front Immunol; 2022; 13():994019. PubMed ID: 36177006
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
[TBL] [Abstract][Full Text] [Related]
29. Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma.
Wei L; Lian B; Zhang Y; Li W; Gu J; He X; Xie L
BMC Genomics; 2014; 15 Suppl 1(Suppl 1):S13. PubMed ID: 24564407
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
31. High Expression of Ten Eleven Translocation 1 Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Wen H; Ji T; Lin L; Cheng N; Zhu K; Cao L
Mediators Inflamm; 2023; 2023():2664370. PubMed ID: 37181808
[TBL] [Abstract][Full Text] [Related]
32. Identification of key snoRNAs serves as biomarkers for hepatocellular carcinoma by bioinformatics methods.
Xie Q; Zhang D; Ye H; Wu Z; Sun Y; Shen H
Medicine (Baltimore); 2022 Sep; 101(39):e30813. PubMed ID: 36181013
[TBL] [Abstract][Full Text] [Related]
33. A predictive and prognostic model for hepatocellular carcinoma with microvascular invasion based TCGA database genomics.
Wang J; Ding ZW; Chen K; Liu YZ; Li N; Hu MG
BMC Cancer; 2021 Dec; 21(1):1337. PubMed ID: 34911488
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
35. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
36. Cell division cycle-associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma.
Wu H; Liu S; Wu D; Zhou H; Sui G; Wu G
Cancer Med; 2023 Apr; 12(8):10138-10155. PubMed ID: 36855818
[TBL] [Abstract][Full Text] [Related]
37. Identification of immune-infiltrating cell-related biomarkers in hepatocellular carcinoma based on gene co-expression network analysis.
Hou Y; Zhang G
Diagn Pathol; 2021 Jul; 16(1):57. PubMed ID: 34218795
[TBL] [Abstract][Full Text] [Related]
38. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
Wang Y; Song F; Zhang X; Yang C
Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
[TBL] [Abstract][Full Text] [Related]
40. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients.
Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y
Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]